Louis Christodoulou

The FcRn inhibitor rozanolixizumab reduces human serum IgG concentration: A randomized phase 1 study

Rocío Lledó‐García, Shikiko Watanabe, Grant Langdon et al. · Science Translational Medicine · 2017 · 195 citations

Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration

Bryan Smith, Rocío Lledó‐García, Kate L. Dixon et al. · mAbs · 2018 · 110 citations · Full text

Immunocytochemical Technique, Immunotoxicology, Antibody Isolation +18

A Mixture of Functionally Oligoclonal Humanized Monoclonal Antibodies That Neutralize Clostridium difficile TcdA and TcdB with High Levels of<i>In Vitro</i>Potency Shows<i>In Vivo</i>Protection in a Hamster Infection Model

Nicola L. Davies, Joanne Compson, Brendon MacKenzie et al. · Clinical and Vaccine Immunology · 2013 · 51 citations · Full text

Microbial Pathogens, Immunology, Immunodominance +21

Multivalent Fcγ-receptor engagement by a hexameric Fc-fusion protein triggers Fcγ-receptor internalisation and modulation of Fcγ-receptor functions

Omar Qureshi, Tania F. Rowley, Fabian Junker et al. · Scientific Reports · 2017 · 47 citations · Full text

Fab-dsFv: A bispecific antibody format with extended serum half-life through albumin binding

Emma Davé, Ralph Adams, Oliver Zaccheo et al. · mAbs · 2016 · 41 citations · Full text

Immunocytochemical Technique, Immunology, Pathology +16